{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T15:37:57Z","timestamp":1785598677559,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.nbd.2009.06.011","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T06:04:17Z","timestamp":1247119457000},"page":"413-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Y-27632 improves rotarod performance and reduces huntingtin levels in R6\/2 mice"],"prefix":"10.1016","volume":"36","author":[{"given":"Mei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aye Aye K.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc I.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2009.06.011_bib1","doi-asserted-by":"crossref","unstructured":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group, 1993. Cell. 72, 971\u201383.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"10.1016\/j.nbd.2009.06.011_bib2","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1073\/pnas.2628045100","article-title":"A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila","volume":"100","author":"Apostol","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.06.011_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.wco.0000084223.82329.bb","article-title":"Experimental therapeutics in Huntington's disease: are models useful for therapeutic trials?","volume":"16","author":"Bates","year":"2003","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2009.06.011_bib4","doi-asserted-by":"crossref","first-page":"13153","DOI":"10.1074\/jbc.M809229200","article-title":"Inhibition of rho-kinases enhances the degradation of mutant huntingtin","volume":"284","author":"Bauer","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.06.011_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.nbd.2008.02.007","article-title":"Expression of expanded polyglutamine targets profilin for degradation and alters actin dynamics","volume":"30","author":"Burnett","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2009.06.011_bib6","doi-asserted-by":"crossref","first-page":"23950","DOI":"10.1074\/jbc.M800467200","article-title":"A common motif targets huntingtin and the androgen receptor to the proteasome","volume":"283","author":"Chandra","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.06.011_bib7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/77528","article-title":"Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease","volume":"6","author":"Chen","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2009.06.011_bib8","doi-asserted-by":"crossref","first-page":"16685","DOI":"10.1073\/pnas.0707842104","article-title":"A small-molecule therapeutic lead for Huntington's disease: preclinical pharmacology and efficacy of C2-8 in the R6\/2 transgenic mouse","volume":"104","author":"Chopra","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.06.011_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","article-title":"CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model","volume":"93","author":"Chou","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.06.011_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2009.06.011_bib11","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.06.011_bib12","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.06.011_bib13","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","article-title":"Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease","volume":"24","author":"Ferrante","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.06.011_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1471-4159.2004.02726.x","article-title":"Cystamine increases l-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation","volume":"91","author":"Fox","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.06.011_bib15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.molcel.2004.09.016","article-title":"A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease","volume":"15","author":"Goehler","year":"2004","journal-title":"Mol. Cell."},{"key":"10.1016\/j.nbd.2009.06.011_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10094","article-title":"Environmental enrichment slows disease progression in R6\/2 Huntington's disease mice","volume":"51","author":"Hockly","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2009.06.011_bib17","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.06.011_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0361-9230(03)00185-0","article-title":"Standardization and statistical approaches to therapeutic trials in the R6\/2 mouse","volume":"61","author":"Hockly","year":"2003","journal-title":"Brain. Res. Bull."},{"key":"10.1016\/j.nbd.2009.06.011_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/bjp.2008.225","article-title":"Antiepileptic effects of two Rho-kinase inhibitors, Y-27632 and fasudil, in mice","volume":"155","author":"Inan","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2009.06.011_bib20","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0026-895X(24)26508-1","article-title":"Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases","volume":"57","author":"Ishizaki","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2009.06.011_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng864","article-title":"A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila","volume":"30","author":"Kazantsev","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2009.06.011_bib22","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1074\/jbc.M609972200","article-title":"Soluble androgen receptor oligomers underlie pathology in a mouse model of spinobulbar muscular atrophy","volume":"282","author":"Li","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.06.011_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2009.06.011_bib24","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4161\/auto.6502","article-title":"Protein misfolding and cardiac disease: establishing cause and effect","volume":"4","author":"Pattison","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.nbd.2009.06.011_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0896-6273(03)00697-4","article-title":"A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor","volume":"40","author":"Pollitt","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2009.06.011_bib26","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.mam.2006.08.008","article-title":"Role of autophagy in the clearance of mutant huntingtin: a step towards therapy?","volume":"27","author":"Ravikumar","year":"2006","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.nbd.2009.06.011_bib27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2009.06.011_bib28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","article-title":"Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo","volume":"90","author":"Scherzinger","year":"1997","journal-title":"Cell"},{"issue":"Spec No. 2","key":"10.1016\/j.nbd.2009.06.011_bib29","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1093\/hmg\/ddm213","article-title":"Polyglutamine diseases: emerging concepts in pathogenesis and therapy.","volume":"16","author":"Shao","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2009.06.011_bib30","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.febslet.2008.04.009","article-title":"ROCK and PRK-2 mediate the inhibitory effect of Y-27632 on polyglutamine aggregation","volume":"582","author":"Shao","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2009.06.011_bib31","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1128\/MCB.00079-08","article-title":"Phosphorylation of profilin by ROCK1 regulates polyglutamine aggregation","volume":"28","author":"Shao","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2009.06.011_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2005.06.003","article-title":"Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial","volume":"238","author":"Shibuya","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2009.06.011_bib33","article-title":"Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic","author":"Takahashi","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2009.06.011_bib34","doi-asserted-by":"crossref","first-page":"24039","DOI":"10.1074\/jbc.M704789200","article-title":"Detection of polyglutamine protein oligomers in cells by fluorescence correlation spectroscopy","volume":"282","author":"Takahashi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.06.011_bib35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nm985","article-title":"Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease","volume":"10","author":"Tanaka","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2009.06.011_bib36","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/40187","article-title":"Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension","volume":"389","author":"Uehata","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2009.06.011_bib37","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1101\/gad.1400506","article-title":"Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity","volume":"20","author":"Wang","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.nbd.2009.06.011_bib38","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1073\/pnas.0408936102","article-title":"A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109001600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109001600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:04:36Z","timestamp":1760850276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996109001600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0969996109001600"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2009.06.011","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Y-27632 improves rotarod performance and reduces huntingtin levels in R6\/2 mice","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2009.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}